The cardiovascular system appears to adapt well to microgravity but is
compromised on reestablishment of gravitational forces leading to ort
hostatic intolerance and a reduction in work capacity. However, maxima
l systemic oxygen uptake (Vo(2)) and transport, which may be viewed as
a measure of the functional integrity of the cardiovascular system an
d its regulatory mechanisms, has not been systematically measured in s
pace or immediately after return to Earth after spaceflight. We studie
d six astronauts (4 men and 2 women, age 35-50 yr) before, during, and
immediately after 9 or 14 days of microgravity on two Spacelab Life S
ciences flights (SLS-1 and SLS-2). Peak Vo(2) (Vo(2peak)) was measured
with an incremental protocol on a cycle ergometer after prolonged sub
maximal exercise at 30 and 60% of Vo(2peak). We measured gas fractions
by mass spectrometer and ventilation via turbine flowmeter for the ca
lculation of breath-by-breath Vo(2), heart rate via electrocardiogram,
and cardiac output (Qc) via carbon dioxide rebreathing. Peak power an
d Vo(2) were well maintained during spaceflight and not significantly
different compared with 2 wk preflight. Vo(2peak) was reduced by 22% i
mmediately postflight (P < 0.05), entirely because of a decrease in pe
ak stroke volume and Qc. Peak heart rate, blood pressure, and systemic
arteriovenous oxygen difference were unchanged. We conclude that syst
emic Vo(2peak) is well maintained in the absence of gravity for 9-14 d
ays but is significantly reduced immediately on return to Earth, most
likely because of reduced intravascular blood volume, stroke volume, a
nd Qc.